Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Portage Biotech Inc. stock logo
ALP
Portage Biotech
$0.17
+2.0%		$0.29
$0.15
▼
$13.80
$4.07M0.6112.43 million shs1.80 million shs
FRMM
Forum Markets
$6.11
-2.2%		$5.68
$1.76
▼
$74.50
$81.74M1.38756,981 shs40,776 shs
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
$6.71
-1.7%		$7.63
$3.01
▼
$11.62
$968.54M1.718.47 million shs3.43 million shs
YARW
Yarrow Bioscience
$42.82
+0.2%		$0.00
$14.02
▼
$46.95
$28.69M1.9611,428 shs3,814 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Portage Biotech Inc. stock logo
ALP
Portage Biotech
-5.67%-6.81%-48.86%-48.86%+16,979,900.00%
FRMM
Forum Markets
+0.81%+2.30%-8.24%+68.65%+623,999,900.00%
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
+1.04%+2.25%-7.34%-2.43%+681,999,900.00%
YARW
Yarrow Bioscience
-0.12%+2.62%+4,271,999,900.00%+4,271,999,900.00%+4,271,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Portage Biotech Inc. stock logo
ALP
Portage Biotech
$0.17
+2.0%		$0.29
$0.15
▼
$13.80
$4.07M0.6112.43 million shs1.80 million shs
FRMM
Forum Markets
$6.11
-2.2%		$5.68
$1.76
▼
$74.50
$81.74M1.38756,981 shs40,776 shs
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
$6.71
-1.7%		$7.63
$3.01
▼
$11.62
$968.54M1.718.47 million shs3.43 million shs
YARW
Yarrow Bioscience
$42.82
+0.2%		$0.00
$14.02
▼
$46.95
$28.69M1.9611,428 shs3,814 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Portage Biotech Inc. stock logo
ALP
Portage Biotech
-5.67%-6.81%-48.86%-48.86%+16,979,900.00%
FRMM
Forum Markets
+0.81%+2.30%-8.24%+68.65%+623,999,900.00%
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
+1.04%+2.25%-7.34%-2.43%+681,999,900.00%
YARW
Yarrow Bioscience
-0.12%+2.62%+4,271,999,900.00%+4,271,999,900.00%+4,271,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Portage Biotech Inc. stock logo
ALP
Portage Biotech
2.00
Hold$2.001,054.73% Upside
FRMM
Forum Markets
2.50
Moderate Buy$10.0063.80% Upside
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
2.50
Moderate Buy$12.7289.66% Upside
YARW
Yarrow Bioscience
3.00
Buy$58.0035.47% Upside

Current Analyst Ratings Breakdown

Latest PURR, FRMM, YARW, and ALP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
YARW
Yarrow Bioscience
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold ➝ Buy$58.00
7/28/2026
YARW
Yarrow Bioscience
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy
7/24/2026
Portage Biotech Inc. stock logo
ALP
Portage Biotech
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/21/2026
FRMM
Forum Markets
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/1/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$8.00 ➝ $18.40
6/30/2026
FRMM
Forum Markets
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/12/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
Chardan Capital logo
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$9.75
6/3/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
5/29/2026
FRMM
Forum Markets
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
5/20/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (D)
5/20/2026
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
Chardan Capital logo
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$8.45 ➝ $9.75
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Portage Biotech Inc. stock logo
ALP
Portage Biotech
$100K40.65N/AN/A$0.28 per share0.62
FRMM
Forum Markets
$9.41M8.69N/AN/A$12.59 per share0.48
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
$1M968.54N/AN/A$1.52 per share4.41
YARW
Yarrow Bioscience
$570K50.33N/AN/A$41.71 per share1.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Portage Biotech Inc. stock logo
ALP
Portage Biotech
-$38.63M-$8.18N/AN/AN/AN/AN/AN/AN/A
FRMM
Forum Markets
-$450.52M-$36.07N/A38.16N/AN/A-242.09%-135.46%N/A
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
-$16.01M-$7.37N/AN/AN/AN/A-56.04%-52.22%N/A
YARW
Yarrow Bioscience
-$26.48M-$19.00N/AN/AN/A-4,726.21%-70.42%-63.46%N/A

Latest PURR, FRMM, YARW, and ALP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
FRMM
Forum Markets
-$0.21-$0.73-$0.52-$0.75$3.30 million$1.37 million
8/13/2026Q2 2026
YARW
Yarrow Bioscience
N/A-$2.14N/A-$2.14N/AN/A
7/16/2026Q4 2026
Portage Biotech Inc. stock logo
ALP
Portage Biotech
N/A$0.4750N/A$0.4750N/AN/A
5/14/2026Q1 2026
FRMM
Forum Markets
N/A-$3.64N/A-$3.58N/A$2.86 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Portage Biotech Inc. stock logo
ALP
Portage Biotech
N/AN/AN/AN/AN/A
FRMM
Forum Markets
N/AN/AN/AN/AN/A
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
N/AN/AN/AN/AN/A
YARW
Yarrow Bioscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Portage Biotech Inc. stock logo
ALP
Portage Biotech
0.01
0.31
0.31
FRMM
Forum Markets
0.15
6.19
6.19
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
N/A
18.23
18.22
YARW
Yarrow Bioscience
N/A
20.86
20.86

Institutional Ownership

CompanyInstitutional Ownership
Portage Biotech Inc. stock logo
ALP
Portage Biotech
13.36%
FRMM
Forum Markets
4.07%
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
9.45%
YARW
Yarrow Bioscience
83.78%

Insider Ownership

CompanyInsider Ownership
Portage Biotech Inc. stock logo
ALP
Portage Biotech
N/A
FRMM
Forum Markets
25.20%
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
8.48%
YARW
Yarrow Bioscience
3.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Portage Biotech Inc. stock logo
ALP
Portage Biotech
623.47 millionN/AN/A
FRMM
Forum Markets
713.39 million10.02 millionN/A
Hyperliquid Strategies Inc stock logo
PURR
Hyperliquid Strategies
N/A144.45 million132.20 millionN/A
YARW
Yarrow Bioscience
30670,000648,000N/A

Recent News About These Companies

Analyst Maintains Buy on Yarrow Bioscience, Sees Attractive Risk-Reward with Unchanged $56 Price Target
August 13 at 2:31 PM  |  tipranks.comhttps://www.tipranks.com/news/ratings/analyst-maintains-buy-on-yarrow-bioscience-sees-attractive-risk-reward-with-unchanged-56-price-target-ratings-news?utm_source=marketbeat.com&utm_medium=referral
BTIG Research Begins Coverage on Yarrow Bioscience (NASDAQ:YARW)
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30941361
Yarrow Bioscience Alters Capital Structure With Warrant Exchange
July 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/yarrow-bioscience-alters-capital-structure-with-warrant-exchange?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
A DoorDash-branded delivery drone with a red and white cargo pod flies against a blue sky.
DoorDash's Drone Certification Could Reshape Its Delivery Margins
By Jeffrey Neal Johnson | July 30, 2026
A semiconductor wafer sits on a table in a data center with server racks and a glowing world map overlay.
The AI Chip Blockade Is Creating a Shadow Market
By Jeffrey Neal Johnson | August 4, 2026
Portage Biotech stock logo

Portage Biotech NASDAQ:ALP

$0.17 +0.00 (+2.00%)
As of 12:21 PM Eastern

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Forum Markets NASDAQ:FRMM

$6.10 -0.14 (-2.16%)
As of 12:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Forum Markets Inc is a digital asset platform modernizing capital markets through the tokenization of institutional-grade real-world assets on Ethereum. The company structures cash-generating assets on blockchain-based infrastructure to facilitate liquidity, investor access, and primary and secondary market activity. It combines traditional asset management practices with digital market infrastructure to support the origination, distribution, and trading of real-world assets.

Hyperliquid Strategies stock logo

Hyperliquid Strategies NASDAQ:PURR

$6.70 -0.12 (-1.69%)
As of 12:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK.

Yarrow Bioscience NASDAQ:YARW

$42.82 +0.10 (+0.22%)
As of 12:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas